Dornase Alpha Compared to Hypertonic Saline for Lung Atelectasis in Critically Ill Patients

被引:11
|
作者
Youness, Houssein A. [1 ]
Mathews, Kathryn [2 ]
Elya, Marwan K. [1 ]
Kinasewitz, Gary T. [1 ]
Keddissi, Jean I. [1 ]
机构
[1] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Pharm, Oklahoma City, OK USA
关键词
atelectasis; mechanical ventilation; Dornase alpha; hypertonic saline; RECOMBINANT HUMAN DNASE; POSTOPERATIVE PULMONARY COMPLICATIONS; CYSTIC-FIBROSIS; AIRWAY SECRETIONS; CONTROLLED-TRIAL; SPUTUM; YOUNG;
D O I
10.1089/jamp.2011.0954
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Despite the lack of randomized trials, nebulized Dornase alpha and hypertonic saline are used empirically to treat atelectasis in mechanically ventilated patients. Our objective was to determine the clinical and radiological efficacy of these medications as an adjunct to standard therapy in critically ill patients. Methods: Mechanically ventilated patients with new onset (<48 h) lobar or multilobar atelectasis were randomized into three groups: nebulized Dornase alpha, hypertonic (7%) saline or normal saline every 12 h. All patients received standard therapy, including chest percussion therapy, kinetic therapy, and bronchodilators. The primary endpoint was the change in the daily chest X-ray atelectasis score. Results: A total of 33 patients met the inclusion criteria and were randomized equally into the three groups. Patients in the Dornase alpha group showed a reduction of 2.18 +/- 1.33 points in the CXR score from baseline to day 7, whereas patients in the normal saline group had a reduction of 1.00 +/- 31.79 points, and patients in the hypertonic saline group showed a score reduction of 1.09 +/- 1.51 points. Pairwise comparison of the mean change of the CXR score showed no statistical difference between hypertonic saline, normal saline, and dornase alpha. Airway pressures as well as oxygenation, expressed as PaO2/FIO2 and time to extubation also were similar among groups. During the study period the rate of extubation was 54% (6/11), 45% (5/11), and 63% (7/11) in the normal saline, hypertonic saline, and Dornase alpha groups, respectively (p = 0.09). No treatment related complications were observed. Conclusions: There was no significant improvement in the chest X-ray atelectasis score in mechanically ventilated patients with new onset atelectasis who were nebulized with Dornase alpha twice a day. Hypertonic saline was no more effective than normal saline in this population. Larger randomized control trials are needed to confirm our results.
引用
下载
收藏
页码:342 / 348
页数:7
相关论文
共 50 条
  • [1] Use of intraosseous hypertonic saline in critically ill patients
    Farrokh, Salia
    Cho, Sung-Min
    Lefebvre, Austen T.
    Zink, Elizabeth K.
    Schiavi, Adam
    Puttgen, Hans A.
    JOURNAL OF VASCULAR ACCESS, 2019, 20 (04): : 427 - 432
  • [2] Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline
    Tran, Lena K.
    Marino, Kaylee K.
    DeGrado, Jeremy R.
    Szumita, Paul M.
    Dube, Kevin M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (06): : 711 - 717
  • [3] Hypertonic Saline in the Critically Ill: A Review of Indications, Routes, and Dosing
    Jonathan Dangers
    Maria Enders
    Travis Helberg
    Current Emergency and Hospital Medicine Reports, 2023, 11 : 95 - 102
  • [4] Hypertonic Saline in the Critically Ill: A Review of Indications, Routes, and Dosing
    Dangers, Jonathan
    Enders, Maria
    Helberg, Travis
    CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS, 2023, 11 (3) : 95 - 102
  • [5] Safety of Peripheral Administration of 3% Hypertonic Saline in Critically Ill Patients: A Literature Review
    Alenazi, Ahmed O.
    Alhalimi, Zahra M.
    Almatar, Manar H.
    Alhajji, Taha A.
    CRITICAL CARE NURSE, 2021, 41 (01) : 25 - 31
  • [6] Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Claudius C.
    Perner A.
    Møller M.H.
    Systematic Reviews, 4 (1)
  • [7] Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis
    Singer, Florian
    Stanojevic, Sanja
    Yammine, Sophie
    Subbarao, Padmaja
    Jensen, Renee
    Amin, Reshma
    Ratjen, Felix
    Latzin, Philipp
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [8] Effect of Hypertonic Saline on Adequacy of Resuscitation, Progression of Inflammation and Outcome of Critically Ill Septic Patients.
    Elgawaby, Helmy
    Shehata, Mohamed
    Sabri, Sherif
    Soliman, Mohamed
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2011, 8 (04): : 1148 - 1153
  • [9] HYPERTONIC SALINE IN CRITICALLY ILL PATIENTS REDUCES NEUTROPHIL ADHESION RECEPTOR EXPRESSION AND RESTORES RESPIRATORY BURST
    Pascual, Jose
    Ding, Weiwei
    Sarani, Babak
    Peterson, Jennifer
    Abdurraheim, Nuri
    Aized, Majid
    Sims, Carrie
    Gracias, Vicente
    Schwab, William
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A63 - A63
  • [10] Extended Lung Ultrasound to Differentiate Between Pneumonia and Atelectasis in Critically Ill Patients: A Diagnostic Accuracy Study
    Haaksma, Mark E.
    Smit, Jasper M.
    Heldeweg, Micah L. A.
    Nooitgedacht, Jip S.
    de Grooth, Harm J.
    Jonkman, Annemijn H.
    Girbes, Armand R. J.
    Heunks, Leo
    Tuinman, Pieter R.
    CRITICAL CARE MEDICINE, 2022, 50 (05) : 750 - 759